To determine whether the decrease in PRH protein levels seen on treatment with Niclosamide is essential for the effects of Niclosamide on the CCA cells we made use of CCLP cells in which PRH expression has been knocked out using CRISPR targeting. The gene discussed is HHEX; the disease is cholangiocarcinoma.